Stryker Corporation $SYK is Fundsmith LLP’s 2nd Largest Position

Fundsmith LLP lowered its stake in shares of Stryker Corporation (NYSE:SYK) by 4.8% during the 2nd quarter, HoldingsChannel.com reports. The firm owned 2,913,833 shares of the medical technology company’s stock after selling 147,583 shares during the quarter. Stryker makes up 6.7% of Fundsmith LLP’s holdings, making the stock its 2nd biggest position. Fundsmith LLP’s holdings in Stryker were worth $917,391,000 at the end of the most recent reporting period.

A number of other institutional investors also recently bought and sold shares of the stock. State Street Corp increased its position in Stryker by 2.1% during the fourth quarter. State Street Corp now owns 15,254,407 shares of the medical technology company’s stock valued at $5,374,731,000 after acquiring an additional 311,507 shares during the last quarter. Wellington Management Group LLP lifted its holdings in shares of Stryker by 0.6% in the 2nd quarter. Wellington Management Group LLP now owns 8,167,185 shares of the medical technology company’s stock worth $2,571,357,000 after acquiring an additional 45,478 shares during the last quarter. Geode Capital Management LLC lifted its holdings in shares of Stryker by 0.9% in the 4th quarter. Geode Capital Management LLC now owns 7,535,572 shares of the medical technology company’s stock worth $2,636,238,000 after acquiring an additional 69,851 shares during the last quarter. Norges Bank purchased a new position in shares of Stryker during the 4th quarter worth about $1,822,272,000. Finally, Bank of America Corp DE bought a new position in Stryker during the 2nd quarter valued at about $1,404,284,000. 77.09% of the stock is currently owned by institutional investors.

Insider Buying and Selling at Stryker

In other news, insider Dylan Bram Crotty sold 441 shares of the stock in a transaction that occurred on Friday, August 21st. The shares were sold at an average price of $328.61, for a total transaction of $144,917.01. Following the transaction, the insider directly owned 6,102 shares in the company, valued at approximately $2,005,178.22. This trade represents a 6.74% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Debra King sold 826 shares of Stryker stock in a transaction that occurred on Tuesday, August 18th. The shares were sold at an average price of $336.30, for a total transaction of $277,783.80. Following the transaction, the insider directly owned 6,210 shares in the company, valued at approximately $2,088,423. The trade was a 11.74% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last quarter, insiders have sold 351,267 shares of company stock valued at $118,197,701. Company insiders own 4.60% of the company’s stock.

Analyst Ratings Changes

SYK has been the subject of several analyst reports. Weiss Ratings reissued a “hold (c)” rating on shares of Stryker in a research note on Friday, July 31st. Leerink Partners reduced their price target on Stryker from $410.00 to $407.00 and set an “outperform” rating on the stock in a report on Friday, June 5th. JPMorgan Chase & Co. decreased their price target on Stryker from $400.00 to $350.00 and set an “overweight” rating for the company in a research note on Friday, July 31st. UBS Group assumed coverage on Stryker in a research note on Tuesday, July 28th. They issued a “buy” rating and a $400.00 target price on the stock. Finally, Citigroup reissued a “buy” rating on shares of Stryker in a research report on Thursday, August 13th. One equities research analyst has rated the stock with a Strong Buy rating, seventeen have issued a Buy rating and six have issued a Hold rating to the stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $386.28.

Stryker Price Performance

Shares of SYK stock opened at $331.32 on Monday. Stryker Corporation has a twelve month low of $281.00 and a twelve month high of $396.86. The company has a current ratio of 2.16, a quick ratio of 1.33 and a debt-to-equity ratio of 0.59. The stock has a fifty day simple moving average of $329.10 and a two-hundred day simple moving average of $331.29. The stock has a market capitalization of $127.08 billion, a price-to-earnings ratio of 34.33, a P/E/G ratio of 2.11 and a beta of 0.76.

Stryker (NYSE:SYK) last announced its quarterly earnings results on Thursday, July 30th. The medical technology company reported $3.69 EPS for the quarter, beating the consensus estimate of $3.49 by $0.20. The firm had revenue of $6.59 billion for the quarter, compared to analyst estimates of $6.58 billion. Stryker had a return on equity of 23.63% and a net margin of 14.43%.The business’s revenue for the quarter was up 9.4% on a year-over-year basis. During the same quarter last year, the firm posted $3.13 earnings per share. Stryker has set its FY 2026 guidance at 14.950-15.100 EPS. On average, analysts predict that Stryker Corporation will post 15.02 EPS for the current fiscal year.

Stryker Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 30th. Shareholders of record on Wednesday, September 30th will be given a dividend of $0.88 per share. The ex-dividend date of this dividend is Wednesday, September 30th. This represents a $3.52 dividend on an annualized basis and a yield of 1.1%. Stryker’s dividend payout ratio (DPR) is 36.48%.

Stryker Company Profile

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.